- Pennsylvania. The
company was
formerly known as
Tekmira,
which was spun out of Inex
Pharmaceuticals in 2007.
Tekmira, as the
company was
formerly called, was...
- drug for
Ebola disease that was
developed by
Arbutus Biopharma (formerly
Tekmira Pharmaceuticals Corp.) in Vancouver, Canada. The drug
candidate was formerly...
- Team. He was
chairman of
OnCore Biopharma, a
position he
maintained at
Tekmira Pharmaceuticals when the two
companies merged in
March 2015. He also was...
-
Recruiting Tekmira Pharmaceutical NCT01262235 TKM–100201 VP24, VP35,
Zaire Ebola L-polymerase LNP Ebola-virus
infection I
Recruiting Tekmira Pharmaceutical...
-
approve their chemotherapy products. Inex then
downsized and
rebranded to
Tekmira Pharmaceuticals. This led to $28.5
million in
funding from “large biotechnology...
- Biopharma,
formerly as
OnCore Biopharma prior to its 2015
merger with
Tekmira Pharmaceuticals.
Michael J.
Sofia was
awarded the 2016 Lasker-DeBakey Clinical...
- (nanoparticle
lipidoid coatings) and
licensed technology from
Alnylam and
Tekmira. In 2012
Syngenta acquired Devgen, a
European RNA partner.
Startup Forest...
- an
Ebola treatment being developed by
Canadian pharmaceutical company Tekmira to the Fast
Track program, but
halted the
phase 1
trials in July pending...
- work with him on the
chemically altered mRNA. Initially,
MacLachlan and
Tekmira turned away from the collaboration. Karikó
wanted to team up with Ian MacLachlan...
-
oligomers (PMOs)
targeting the MARV
genome New
therapies from
Sarepta and
Tekmira have also been
successfully used in
humans as well as primates. List of...
